These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 28306482)

  • 21. Voriconazole therapeutic drug monitoring in allogeneic hematopoietic stem cell transplant recipients.
    Trifilio S; Ortiz R; Pennick G; Verma A; Pi J; Stosor V; Zembower T; Mehta J
    Bone Marrow Transplant; 2005 Mar; 35(5):509-13. PubMed ID: 15654347
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lung transplant recipients receiving voriconazole and skin squamous cell carcinoma risk in Australia.
    Neoh CF; Snell GI; Levvey B; Kotsimbos T; Morrissey O; Slavin MA; Stewart K; Kong DC
    Med J Aust; 2014 Nov; 201(9):543-4. PubMed ID: 25358582
    [No Abstract]   [Full Text] [Related]  

  • 23. Reduction in incidence of invasive fungal infection in patients receiving allogeneic stem cell transplantation using combined diagnostic-driven approach and itraconazole oral solution.
    Tzadok R; Shapira MY; Moses AE; Or R; Block C; Strahilevitz J
    Mycoses; 2015 Dec; 58(12):694-8. PubMed ID: 26429354
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Therapeutic drug monitoring of voriconazole helps to decrease the percentage of patients with off-target trough serum levels.
    Guinea J; Escribano P; Marcos-Zambrano LJ; Peláez T; Kestler M; Muñoz P; Vena A; López-Fabal F; Bouza E
    Med Mycol; 2016 May; 54(4):353-60. PubMed ID: 26739190
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Incidence of invasive aspergillosis among allogeneic hematopoietic stem cell transplant patients receiving voriconazole prophylaxis.
    Siwek GT; Pfaller MA; Polgreen PM; Cobb S; Hoth P; Magalheas-Silverman M; Diekema DJ
    Diagn Microbiol Infect Dis; 2006 Jul; 55(3):209-12. PubMed ID: 16626917
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of Obesity on Voriconazole Pharmacokinetics among Pediatric Hematopoietic Cell Transplant Recipients.
    Takahashi T; Smith AR; Jacobson PA; Fisher J; Rubin NT; Kirstein MN
    Antimicrob Agents Chemother; 2020 Nov; 64(12):. PubMed ID: 32988816
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of Gender and Age on Voriconazole Trough Concentrations in Italian Adult Patients.
    Allegra S; De Francia S; De Nicolò A; Cusato J; Avataneo V; Manca A; Antonucci M; D'Avolio A
    Eur J Drug Metab Pharmacokinet; 2020 Jun; 45(3):405-412. PubMed ID: 31965553
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Breakthrough disseminated Aspergillus ustus infection in allogeneic hematopoietic stem cell transplant recipients receiving voriconazole or caspofungin prophylaxis.
    Pavie J; Lacroix C; Hermoso DG; Robin M; Ferry C; Bergeron A; Feuilhade M; Dromer F; Gluckman E; Molina JM; Ribaud P
    J Clin Microbiol; 2005 Sep; 43(9):4902-4. PubMed ID: 16145172
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Voriconazole metabolism is influenced by severe inflammation: a prospective study.
    Veringa A; Ter Avest M; Span LF; van den Heuvel ER; Touw DJ; Zijlstra JG; Kosterink JG; van der Werf TS; Alffenaar JC
    J Antimicrob Chemother; 2017 Jan; 72(1):261-267. PubMed ID: 27601292
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Voriconazole pharmacokinetics following HSCT: results from the BMT CTN 0101 trial.
    Hope WW; Walsh TJ; Goodwin J; Peloquin CA; Howard A; Kurtzberg J; Mendizabal A; Confer DL; Bulitta J; Baden LR; Neely MN; Wingard JR;
    J Antimicrob Chemother; 2016 Aug; 71(8):2234-40. PubMed ID: 27121401
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Voriconazole for prophylaxis of invasive fungal infections after allogeneic hematopoietic stem cell transplantation.
    Marks DI; Liu Q; Slavin M
    Expert Rev Anti Infect Ther; 2017 May; 15(5):493-502. PubMed ID: 28335642
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Voriconazole exposure and the risk of cutaneous squamous cell carcinoma in allogeneic hematopoietic stem cell transplant patients.
    Wojenski DJ; Bartoo GT; Merten JA; Dierkhising RA; Barajas MR; El-Azhary RA; Wilson JW; Plevak MF; Hogan WJ; Litzow MR; Patnaik MM; Wolf RC; Hashmi SK
    Transpl Infect Dis; 2015 Apr; 17(2):250-8. PubMed ID: 25661996
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Voriconazole tolerability in lung transplant recipients: Is N-oxide metabolite responsible for phototoxicity?
    Soresi S; Sabashnikov A; Leaver N; Zeriouh M; Simon AR; Popov AF; Carby M
    J Heart Lung Transplant; 2015 Oct; 34(10):1354-5. PubMed ID: 26212657
    [No Abstract]   [Full Text] [Related]  

  • 34. Genotype-Directed Dosing Leads to Optimized Voriconazole Levels in Pediatric Patients Receiving Hematopoietic Stem Cell Transplantation.
    Teusink A; Vinks A; Zhang K; Davies S; Fukuda T; Lane A; Nortman S; Kissell D; Dell S; Filipovich A; Mehta P
    Biol Blood Marrow Transplant; 2016 Mar; 22(3):482-6. PubMed ID: 26616742
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Voriconazole and sirolimus coadministration after allogeneic hematopoietic stem cell transplantation.
    Marty FM; Lowry CM; Cutler CS; Campbell BJ; Fiumara K; Baden LR; Antin JH
    Biol Blood Marrow Transplant; 2006 May; 12(5):552-9. PubMed ID: 16635790
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inflammation is a potential risk factor of voriconazole overdose in hematological patients.
    Gautier-Veyret E; Truffot A; Bailly S; Fonrose X; Thiebaut-Bertrand A; Tonini J; Cahn JY; Stanke-Labesque F
    Fundam Clin Pharmacol; 2019 Apr; 33(2):232-238. PubMed ID: 30306637
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Voriconazole Therapeutic Drug Monitoring Practices in Intensive Care.
    van Wanrooy MJ; Rodgers MG; Span LF; Zijlstra JG; Uges DR; Kosterink JG; van der Werf TS; Alffenaar JW
    Ther Drug Monit; 2016 Jun; 38(3):313-8. PubMed ID: 26845112
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interaction between voriconazole and flucloxacillin during treatment of disseminated Scedosporium apiospermum infection.
    Kennedy B; Larcombe R; Chaptini C; Gordon DL
    J Antimicrob Chemother; 2015 Jul; 70(7):2171-3. PubMed ID: 25777322
    [No Abstract]   [Full Text] [Related]  

  • 39. Dose optimisation of voriconazole with therapeutic drug monitoring in children: a single-centre experience in China.
    Liu L; Zhou X; Wu T; Jiang H; Yang S; Zhang Y
    Int J Antimicrob Agents; 2017 Apr; 49(4):483-487. PubMed ID: 28159657
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of voriconazole on risk of nonmelanoma skin cancer after hematopoietic cell transplantation.
    Kuklinski LF; Li S; Karagas MR; Weng WK; Kwong BY
    J Am Acad Dermatol; 2017 Oct; 77(4):706-712. PubMed ID: 28780363
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.